Speech generating devices are not simple consumer products. They are medical tools that require proper evaluation, customization, and ongoing support by a licensed clinician to be effective. When those elements are missing or fragmented, patients may not receive the full benefit of the technology.
Fact 1: Communication Devices Require Full Integration and Support
Effective communication solutions include more than hardware and software. They require:
- Clinical evaluation by a clinician
- Custom configuration based on the individual’s assessed needs
- Training for patients, families, and caregivers
- Ongoing technical and clinical support
These elements are designed, tested, and certified to work together. When they are properly integrated, patients are more likely to achieve meaningful communication outcomes.
Fact 2: TD Snap® Software Is Licensed for Specific Use
TD Snap® is proprietary software developed and maintained by Tobii Dynavox. It is licensed under specific terms that govern how it can be used, distributed, and supported.
These terms are in place to:
- Protect the integrity of the software
- Ensure proper use in clinical settings
- Support long-term functionality and updates
Using the software outside of these conditions can create gaps in support and accountability.
Fact 3: The Lawsuit Alleges Unauthorized Use of Software
Tobii Dynavox alleges that AbleNet enables the use of TD Snap® software on its devices without authorization.
According to the complaint, this includes:
- Directing patients or clinicians to download TD Snap® onto AbleNet provided devices
- Providing generic Apple gift cards to facilitate software purchases
- Structuring the process so the software is obtained outside of authorized channels
These actions are alleged to bypass licensing restrictions and avoid the responsibilities that come with delivering a fully supported communication solution.
Fact 4: AbleNet Does Not Provide Integrated Software Support
The complaint alleges that AbleNet does not research, develop, control, or fully support the software used on its devices.
Instead, it:
- Relies on third-party software it does not own or manage
- Directs users to external resources for support
- Provides limited ability to troubleshoot or maintain software performance
This can create uncertainty about who is responsible for ongoing support and may leave patients and clinicians without a clear path for assistance.
Fact 5: These Practices Create Confusion
Tobii Dynavox alleges that these practices may create confusion among:
- Patients and families
- Clinicians
- Healthcare payors
Specifically, there may be confusion about:
- Whether the device is a fully integrated speech generating device
- Who is responsible for software support
- Whether there is a relationship between AbleNet and Tobii Dynavox
Clear understanding of these roles is critical to ensuring proper care and accountability.
Fact 6: Communication Devices Are Funded with Expectations
Speech generating devices are often reimbursed through Medicare and other healthcare programs.
These programs typically expect that:
- Devices are delivered as complete, functional solutions
- Patients receive appropriate training and support
- Suppliers are responsible for ongoing service over time
The lawsuit raises questions about how these expectations are fulfilled and supported over time.
Fact 7: Patients May Be Locked Into Their Device
Under many reimbursement models, patients may remain with a device for multiple years.
This means:
- Initial delivery and setup are critically important
- Gaps in support can persist over time
- Switching devices may not be immediately possible
As a result, how a device is delivered and supported at the outset can have long-term implications for patient outcomes.
Fact 8: Tobii Dynavox Attempted to Resolve This Without Litigation
Tobii Dynavox made multiple efforts to address these concerns directly, including formal correspondence and cease-and-desist requests.
According to the complaint, these efforts did not resolve the issue, leading to the decision to pursue legal action.
Fact 9: This Is About Standards, Not Limiting Access
Tobii Dynavox supports broad access to communication technology.
This legal action by Tobii Dynavox is focused on:
- Ensuring responsible delivery of devices
- Protecting patients and clinicians from gaps in support
- Upholding clinical, technical, and regulatory standards
The goal is not to restrict access, but to ensure that Tobii Dynavox’s software has the best chance to create meaningful, supported outcomes.